These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33451136)

  • 1. BoHV-1-Vectored BVDV-2 Subunit Vaccine Induces BVDV Cross-Reactive Cellular Immune Responses and Protects against BVDV-2 Challenge.
    Chowdhury SI; Pannhorst K; Sangewar N; Pavulraj S; Wen X; Stout RW; Mwangi W; Paulsen DB
    Vaccines (Basel); 2021 Jan; 9(1):. PubMed ID: 33451136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant Bovine Herpesvirus Type I Expressing the Bovine Viral Diarrhea Virus E2 Protein Could Effectively Prevent Infection by Two Viruses.
    Liu CY; Guo H; Zhao HZ; Hou LN; Wen YJ; Wang FX
    Viruses; 2022 Jul; 14(8):. PubMed ID: 35893683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A recombinant bovine herpesvirus-4 vectored vaccine delivered via intranasal nebulization elicits viral neutralizing antibody titers in cattle.
    Williams LBA; Fry LM; Herndon DR; Franceschi V; Schneider DA; Donofrio G; Knowles DP
    PLoS One; 2019; 14(4):e0215605. PubMed ID: 31002724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Triple Gene-Deleted Pseudorabies Virus-Vectored Subunit PCV2b and CSFV Vaccine Protects Pigs against PCV2b Challenge and Induces Serum Neutralizing Antibody Response against CSFV.
    Pavulraj S; Pannhorst K; Stout RW; Paulsen DB; Carossino M; Meyer D; Becher P; Chowdhury SI
    Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Priming Cross-Protective Bovine Viral Diarrhea Virus-Specific Immunity Using Live-Vectored Mosaic Antigens.
    Lokhandwala S; Fang X; Waghela SD; Bray J; Njongmeta LM; Herring A; Abdelsalam KW; Chase C; Mwangi W
    PLoS One; 2017; 12(1):e0170425. PubMed ID: 28099492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of reproductive protection against bovine viral diarrhea virus and bovine herpesvirus-1 afforded by annual revaccination with modified-live viral or combination modified-live/killed viral vaccines after primary vaccination with modified-live viral vaccine.
    Walz PH; Givens MD; Rodning SP; Riddell KP; Brodersen BW; Scruggs D; Short T; Grotelueschen D
    Vaccine; 2017 Feb; 35(7):1046-1054. PubMed ID: 28111144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A triple gene mutant of BoHV-1 administered intranasally is significantly more efficacious than a BoHV-1 glycoprotein E-deleted virus against a virulent BoHV-1 challenge.
    Chowdhury SI; Wei H; Weiss M; Pannhorst K; Paulsen DB
    Vaccine; 2014 Sep; 32(39):4909-15. PubMed ID: 25066735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vaccination of pregnant beef heifers on the concentrations of serum IgG and specific antibodies to bovine herpesvirus 1, bovine viral diarrhea virus 1, and bovine viral diarrhea virus 2 in heifers and calves.
    Reppert EJ; Chamorro MF; Robinson L; Cernicchiaro N; Wick J; Weaber RL; Haines DM
    Can J Vet Res; 2019 Oct; 83(4):313-316. PubMed ID: 31571732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of vaccination with a multivalent modified-live viral vaccine on reproductive performance in synchronized beef heifers.
    Walz PH; Edmondson MA; Riddell KP; Braden TD; Gard JA; Bayne J; Joiner KS; Galik PK; Zuidhof S; Givens MD
    Theriogenology; 2015 Mar; 83(5):822-31. PubMed ID: 25515363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One year duration of immunity of the modified live bovine viral diarrhea virus type 1 and type 2 and bovine herpesvirus-1 fractions of Vista® Once SQ vaccine.
    Purtle L; Mattick D; Schneider C; Smith L; Xue W; Trigo E
    Vaccine; 2016 Mar; 34(13):1582-1588. PubMed ID: 26859238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus detection by PCR following vaccination of naive calves with intranasal or injectable multivalent modified-live viral vaccines.
    Walz PH; Newcomer BW; Riddell KP; Scruggs DW; Cortese VS
    J Vet Diagn Invest; 2017 Sep; 29(5):628-635. PubMed ID: 28545321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of reproductive performance of primiparous dairy cattle following revaccination with either modified-live or killed multivalent viral vaccines in early lactation.
    Walz PH; Montgomery T; Passler T; Riddell KP; Braden TD; Zhang Y; Galik PK; Zuidhof S
    J Dairy Sci; 2015 Dec; 98(12):8753-63. PubMed ID: 26454300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of four commercially available multivalent modified-live virus vaccines against clinical disease, viremia, and viral shedding in early-weaned beef calves exposed simultaneously to cattle persistently infected with bovine viral diarrhea virus and cattle acutely infected with bovine herpesvirus 1.
    Chamorro MF; Walz PH; Passler T; Palomares R; Newcomer BW; Riddell KP; Gard J; Zhang Y; Galik P
    Am J Vet Res; 2016 Jan; 77(1):88-97. PubMed ID: 26709942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bovine viral diarrhea virus E2 protein formulated with a novel adjuvant induces strong, balanced immune responses and provides protection from viral challenge in cattle.
    Snider M; Garg R; Brownlie R; van den Hurk JV; van Drunen Littel-van den Hurk S
    Vaccine; 2014 Nov; 32(50):6758-64. PubMed ID: 25454860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an APC-targeted multivalent E2-based vaccine against Bovine Viral Diarrhea Virus types 1 and 2.
    Pecora A; Malacari DA; Perez Aguirreburualde MS; Bellido D; Nuñez MC; Dus Santos MJ; Escribano JM; Wigdorovitz A
    Vaccine; 2015 Sep; 33(39):5163-71. PubMed ID: 26279338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of an inactivated Chinese bovine viral diarrhea virus 1a (BVDV 1a) vaccine cross protects from BVDV 1b infection in young calves.
    Wang W; Shi X; Wu Y; Li X; Ji Y; Meng Q; Zhang S; Wu H
    Vet Immunol Immunopathol; 2014 Aug; 160(3-4):288-92. PubMed ID: 24880701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of multivalent, modified- live virus (MLV) vaccines administered to early weaned beef calves subsequently challenged with virulent Bovine viral diarrhea virus type 2.
    Chamorro MF; Walz PH; Passler T; van Santen E; Gard J; Rodning SP; Riddell KP; Galik PK; Zhang Y
    BMC Vet Res; 2015 Feb; 11():29. PubMed ID: 25880998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune protection induced by E2 recombinant glycoprotein of bovine viral diarrhea virus in a murine model.
    Gómez-Romero N; Arias CF; Verdugo-Rodríguez A; López S; Valenzuela-Moreno LF; Cedillo-Peláez C; Basurto-Alcántara FJ
    Front Vet Sci; 2023; 10():1168846. PubMed ID: 37426077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and characterization of viruses as field and vaccine strains in feedlot cattle with bovine respiratory disease.
    Fulton RW; d'Offay JM; Landis C; Miles DG; Smith RA; Saliki JT; Ridpath JF; Confer AW; Neill JD; Eberle R; Clement TJ; Chase CC; Burge LJ; Payton ME
    Vaccine; 2016 Jun; 34(30):3478-92. PubMed ID: 27108192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of an inactivated, recombinant bovine herpesvirus type 5 (BoHV-5) vaccine.
    Campos FS; Dezen D; Antunes DA; Santos HF; Arantes TS; Cenci A; Gomes F; Lima FE; Brito WM; Filho HC; Batista HB; Spilki FR; Franco AC; Rijsewijk FA; Roehe PM
    Vet Microbiol; 2011 Feb; 148(1):18-26. PubMed ID: 20828945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.